{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T06:46:33Z","timestamp":1694760393052},"reference-count":11,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["PM&amp;R"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:label \/><jats:p>Tumefactive demyelination is an aggressive, localized, generally solitary area of demyelination that often mimics a neoplasm. We present a case of a 13\u2010year\u2010old female patient who presented with sudden\u2010onset progressive hemiplegia and hemianopsia. Magnetic resonance imaging of the brain showed tumefactive demyelination with partial rim of enhancement. During inpatient rehabilitation, she developed myalgias, rash, and abdominal and mouth pain with evidence for severe neutropenia. The neutropenia was determined to be a secondary complication of the tumefactive disease process. This scenario may be concerning in an inpatient rehabilitation setting, as patients share common areas, increasing the risk of acquired infection while neutropenic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Level of Evidence<\/jats:title><jats:p>V<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.pmrj.2017.12.007","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T20:01:39Z","timestamp":1515528099000},"page":"877-879","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neutropenia as a Complication of Tumefactive Demyelinating Disease: A Case Report"],"prefix":"10.1002","volume":"10","author":[{"given":"Kali","family":"Webb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/B978-141603618-0.10048-7","volume-title":"Textbook of Clinical Neurology","author":"Pirko I.","year":"2007"},{"key":"e_1_2_4_3_2","first-page":"1159","volume-title":"Bradley's Neurology in Clinical Practice","author":"Fabian M.","year":"2015"},{"key":"e_1_2_4_4_2","article-title":"Teriflunomide for multiple sclerosis","volume":"3","author":"He D.","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_4_5_2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1468-1331.2011.03507.x","article-title":"A single\u2010arm, open\u2010label study of alemtuzumab in treatment\u2010refractory patients with multiple sclerosis","volume":"19","author":"Fox E.","year":"2011","journal-title":"Eur J Neurol"},{"key":"e_1_2_4_6_2","first-page":"68","article-title":"The effects of corticosteroids on lymphocyte recirculation in humans: Analysis of the mechanism of impaired lymphocyte migration to lymph node following methylprednisolone administration","volume":"43","author":"Sackstein R.","year":"1995","journal-title":"J Investig Med"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107591"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198937060-00003"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2004.06.015"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.1.566"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2005.11.002"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400807"}],"container-title":["PM&amp;R"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.pmrj.2017.12.007","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934148218300091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934148218300091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.pmrj.2017.12.007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T22:17:45Z","timestamp":1694729865000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1016\/j.pmrj.2017.12.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,9]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1016\/j.pmrj.2017.12.007"],"URL":"https:\/\/doi.org\/10.1016\/j.pmrj.2017.12.007","archive":["Portico"],"relation":{},"ISSN":["1934-1482","1934-1563"],"issn-type":[{"value":"1934-1482","type":"print"},{"value":"1934-1563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,9]]},"assertion":[{"value":"2017-09-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}